# ClinicalTrials.gov record NCT01755572

> PeptideScanner retained ClinicalTrials.gov record NCT01755572 at 2026-07-30T21:43:54.457Z. Its registry update date was 2015-03-25, and PeptideScanner's reviewed identity mapping was liraglutide.

- Evidence object: `story:clinicaltrials-gov-nct01755572-liraglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2015-03-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01755572-liraglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01755572-liraglutide-v1.json
- Content SHA-256: `d8122c56467ee1baeb620b25e1b5f4c54f199f8551599d8e1bbaf17c620ea755`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01755572 ([`ctg-observation-nct01755572-2015-03-25-0ac1d367f022`](#source-ctg-observation-nct01755572-2015-03-25-0ac1d367f022))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01755572 at 2026-07-30T21:43:54.457Z. Its registry update date was 2015-03-25, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct01755572-2015-03-25-0ac1d367f022`](#source-ctg-observation-nct01755572-2015-03-25-0ac1d367f022))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01755572 at 2026-07-30T21:43:54.457Z. Its registry update date was 2015-03-25, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct01755572-2015-03-25-0ac1d367f022`](#source-ctg-observation-nct01755572-2015-03-25-0ac1d367f022))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01755572-2015-03-25-0ac1d367f022`](#source-ctg-observation-nct01755572-2015-03-25-0ac1d367f022))

## Sources

<a id="source-ctg-observation-nct01755572-2015-03-25-0ac1d367f022"></a>
- **ClinicalTrials.gov record NCT01755572 · retained source version 2015-03-25:0ac1d367f0227eaa842a4adac9c98382639563cf57a0895bcb685bbaa11ecf65** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01755572) (`ctg-observation-nct01755572-2015-03-25-0ac1d367f022`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01755572." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01755572-liraglutide-v1.json SHA-256: d8122c56467ee1baeb620b25e1b5f4c54f199f8551599d8e1bbaf17c620ea755.